Allaway; Graham P.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Allaway; Graham P..The latest application filed is for "method for preventing hiv-1 infection of cd4+ cells".

Company Profile

0.18.28

Allaway; Graham P. - Darnestown MD
Allaway; Graham P. - Mohegan Lake NY
Allaway; Graham P. - Moreton Merseyside GB
Allaway; Graham P. - Wilmslow GB
Allaway; Graham P. - Mohegan NY
Allaway; Graham P. - Cheshire GB

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Method For Preventing Hiv-1 Infection Of Cd4+ Cells App 20130211043 - Allaway; Graham P. ; et al.	2013-08-15
Inhibition of HIV-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein Grant 8,318,425 - Salzwedel , et al. November 27, 2	2012-11-27
CCR5 chemokine receptor-specific monoclonal antibodies capable of inhibiting HIV-1 cell fusion Grant 7,935,797 - Allaway , et al. May 3, 2	2011-05-03
Methods for assaying inhibition of HIV-1 envelope glycoprotein-mediated membrane fusion Grant 7,901,685 - Allaway , et al. March 8, 2	2011-03-08
Methods for inhibiting HIV-1 envelope glycoprotein-medicated membrane fusion Grant 7,862,994 - Allaway , et al. January 4, 2	2011-01-04
Methods of inhibiting human immunodeficiency virus type 1 (HIV-1) infection through the administration of CCR5 chemokine receptor antagonists Grant 7,858,298 - Allaway , et al. December 28, 2	2010-12-28
Inhibition of HIV-1 Replication by Disruption of the Processing of the Viral Capsid-Spacer Peptide 1 Protein App 20100221264 - Salzwedel; Karl ; et al.	2010-09-02
Fluorescence resonance energy transfer screening assay for the identification of HIV-1 envelope glycoprotein-medicated cell App 20090155774 - Allaway; Graham P. ; et al.	2009-06-18
Inhibition of HIV-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein Grant 7,537,765 - Salzwedel , et al. May 26, 2	2009-05-26
Inhibition of HIV-1 Replication by Disruption of the Processing of the Viral Capsid-Spacer Peptide 1 Protein App 20080233559 - SALZWEDEL; Karl ; et al.	2008-09-25
Compounds Capable Of Inhibiting Hiv-1 Infection App 20080226651 - Litwin; Virginia M. ; et al.	2008-09-18
Inhibition of Hiv-1 Replication by Disruption of the Processing of the Viral Capsid-Spacer Peptide 1 Protein App 20080200550 - Salzwedel; Karl ; et al.	2008-08-21
Method for preventing HIV-1 infection of CD4 cells App 20080187539 - Allaway; Graham P. ; et al.	2008-08-07
Method for preventing HIV-1 infection of CD4+ Cells App 20080138897 - Allaway; Graham P. ; et al.	2008-06-12
Monoacylated betulin and dihydrobetulin derivatives, preparation thereof and use thereof Grant 7,365,221 - Allaway , et al. April 29, 2	2008-04-29
Compounds capable of inhibiting HIV-1 infection Grant 7,345,153 - Litwin , et al. March 18, 2	2008-03-18
Methods for assaying inhibition of HIV-1 envelope glycoprotein-mediated membrane fusion App 20070048820 - Allaway; Graham P. ; et al.	2007-03-01
Compounds capable of inhibiting HIV-1 infection App 20070025983 - Litwin; Virginia M. ; et al.	2007-02-01
Methods for inhibiting HIV-1 infection Grant 7,118,859 - Litwin , et al. October 10, 2	2006-10-10
Uses of a chemokine receptor for inhibiting HIV-1 infection App 20060194244 - Allaway; Graham P. ; et al.	2006-08-31
Methods for assaying inhibition of HIV-1 envelope glycoprotein-mediated membrane fusion App 20060140977 - Allaway; Graham P. ; et al.	2006-06-29
Method for preventing HIV-1 infection of CD4+ cells App 20060029932 - Allaway; Graham P. ; et al.	2006-02-09
Methods for using resonance energy transfer-based assay of HIV-1 envelope glycoprotein-mediated membrane fusion, and kits for practicing same Grant 6,972,126 - Allaway , et al. December 6, 2	2005-12-06
Monoacylated betulin and dihydrobetulin derivatives, preparation thereof and use thereof App 20050020548 - Allaway, Graham P. ; et al.	2005-01-27
Inhibition of HIV-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein App 20050015039 - Salzwedel, Karl ; et al.	2005-01-20
Inhibition of HIV-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein App 20040265320 - Salzwedel, Karl ; et al.	2004-12-30
Substituted 3',4'-di-O-camphanoyl-(+)-cis-khellactone analogs, compositions thereof, and methods for using thereof Grant 6,768,007 - Lee , et al. July 27, 2	2004-07-27
Monoacylated betulin and dihydrobetulin derivatives, preparation thereof and use thereof App 20040131629 - Allaway, Graham P. ; et al.	2004-07-08
Method for detecting viral inactivating agents App 20040132011 - Allaway, Graham P. ; et al.	2004-07-08
Non-peptidyl moiety-conjugated CD4-gamma2 and CD4-IgG2 immunoconjugates, and uses thereof Grant 6,737,267 - Maddon , et al. May 18, 2	2004-05-18
Uses of a chemokine receptor for inhibiting HIV-1 infection App 20040086528 - Allaway, Graham P. ; et al.	2004-05-06
Assay for detection of viral fusion inhibitors Grant 6,605,427 - Wild , et al. August 12, 2	2003-08-12
Methods For Using Resonance Energy Transfer- Based Assay Of Hiv-1 Envelope Gylcoprotein-mediated Membrane Fusion, And Kits For Practicing Same App 20030044770 - ALLAWAY, GRAHAM P. ; et al.	2003-03-06
Substituted 3',4' -Di-O-camphanoyl-(+)-cis-khellactone analogs, compositions thereof, and methods for using thereof App 20030008891 - Lee, Kuo-Hsiung ; et al.	2003-01-09
Method for preventing HIV-1 infection of CD4+ cells App 20020155429 - Allaway, Graham P. ; et al.	2002-10-24
Assay for detection of viral fusion inhibitors App 20020094521 - Wild, Carl T. ; et al.	2002-07-18
Non-peptidyl moiety-conjugated CD4-gamma2 and CD4 -IgG2 immunoconjugates, and uses thereof App 20020052481 - Maddon, Paul J. ; et al.	2002-05-02
Fluorescence resonance energy transfer screening assay for the identification of HIV-1 envelope glycoprotein-medicated cell App 20020045161 - Allaway, Graham P. ; et al.	2002-04-18
Method for preventing HIV-1 infection of CD4+ cells Grant 6,344,545 - Allaway , et al. February 5, 2	2002-02-05
Method for generating immunogens that elicit neutralizing antibodies against fusion-active regions of HIV envelope proteins App 20020010317 - Wild, Carl T. ; et al.	2002-01-24
Compounds capable of inhibiting HIV-1 infection App 20010046512 - Litwin, Virginia M. ; et al.	2001-11-29
Fluorescence resonance energy transfer screening assay for the identification of compounds that are capable of abrogating macrophage-tropic HIV-1 cell fusion Grant 6,261,763 - Allaway , et al. July 17, 2	2001-07-17
Method for preventing HIV-1 infection of CD4.sup.+ cells Grant 6,107,019 - Allaway , et al. August 22, 2	2000-08-22
Non-peptidyl moiety-conjugated CD4-gamma2 and CD4-IgG2 immunoconjugates, and uses thereof Grant 6,034,223 - Maddon , et al. March 7, 2	2000-03-07
Synergistic composition of CD4-based protein and anti-HIV-1 antibody, and methods of using same Grant 5,817,767 - Allaway , et al. October 6, 1	1998-10-06

Company Registrations

NCAGE Code	46P94	ALLAWAY GRAHAM P
CAGE Code	46P94	ALLAWAY, GRAHAM P

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.